Objectives. Endovascular repair of descending thoracic aortic lesions is associated with a substantial risk of perioperative spinal cord ischaemia (SCI) which may lead to permanent paraplegia.
Introduction
The use of stent-grafts has radically changed the treatment of lesions of the descending thoracic aorta (DTA) and endovascular repair now is considered an alternative to conventional surgery. Compared to conventional surgery, endovascular treatment is associated with a decrease in hospital mortality and postoperative morbidity. 1 However, spinal cord ischaemia (SCI) remains a concern after the treatment of lesions of the DTA by stent-grafts. Although the SCI rates reported in the literature are generally lower than those after conventional surgery, 2 they can still be as high as 12%. 3 Several risk factors have been suggested to explain the onset of SCI, including a past history of surgery for aneurysm of the abdominal aorta (AAA), peri-operative hypotension and the length of the aorta covered. 4 The goal of this study was to review our experience in the endovascular treatment of DTA lesions to define the incidence of SCI and identify factors that contributed to its development.
Material and Methods

Patients
From June 2000 to June 2005, 67 consecutive patients were treated with stent-grafts for lesions of the arch and the DTA. Among them 18 patients were considered high-surgical-risk candidates because of severe co-morbidities including coronary artery disease (myocardial infarction or angina with positive stress test not amenable to revascularization), symptomatic congestive heart failure (LVEF < 40%), aortic stenosis, severe chronic obstructive pulmonary disease, elevated creatinine >200 mmoles/l and/or age over 80. During the study period, only two patients underwent surgical treatment of a DTA aneurysm, one for a tuberculous aneurysm and one for acute rupture with a short distal neck.
Pre-operative imaging
All the patients had high-resolution spiral CT-scans prior to the endovascular procedure. Lengths were calculated using centreline of flow algorithms, 5 which allowed us to analyze the morphology of the lesions to be treated, in terms of their length, maximum diameter and the distance that separated them from the subclavian artery and the celiac trunk. Selective intercostal artery angiography was not performed.
Diseases and therapeutic indications
In 22 patients, the aortic lesion treated was an aneurysm (19 degenerative lesions and 3 mycotic lesions). Seventeen patients had a type B aortic dissection: two patients were treated at the acute phase for impending rupture and uncontrolled hypertension, fifteen patients were treated in the chronic phase for aneurysmal evolution and in this group only one patient was treated as an emergency (painful dissecting aneurysm). The goal of treatment was to seal the primary entry tear, covering at least 10 cm distal to the tear. Eighteen patients had a traumatic injury of the thoracic aorta (acute n ¼ 14, chronic n ¼ 4), 5 patients had a penetrating ulcer, 4 patients had an anastomotic false aneurysm and one patient had an embolic aortic lesion. In 18 cases (26.9%), the procedure was performed in an emergency setting for acute aortic rupture and among these cases only 2 patients had haemorrhagic shock.
Covered stents
The stent-grafts implanted were: Talent (Medtronic, Santa Rosa, CA), and TAG/Excluder (W.L. Gore & Associates, Flagstaff, AZ).
Adapting the attachment zone
If the proximal attachment zone was short (<15 mm), our policy was to cover the left subclavian artery (LSA). Carotid-subclavian bypass or subclavian-carotid transposition were performed in only two anatomical settings: if the patient had only a left vertebral artery or it was the dominant one (right hypoplastic vertebral artery, diameter <50% of the left vertebral artery), and to prevent a type II endoleak when the LSA arose from an aneurysmal aortic segment. If it was necessary to cover the left common carotid artery, an intercarotid bypass was performed. These interventions were realized prior to stent-graft placement. If the distal attachment zone was short, we covered or embolized the celiac trunk, provided angiographic evaluation showed adequate collateral flow through the gastroduodenal and pancreaticoduodenal arteries. 6 
Endovascular procedure
All the procedures were performed in the operating room under general anesthesia with tracheal intubation, mechanical ventilation and strict monitoring of the patient's blood pressure: the mean arterial pressure (MAP) was maintained above 90 mmHg immediately after stent-graft deployment and until the patients awoke and had a neurological examination. An intravenous loading dose of heparin (50 U per kilogram of body weight) was given at the beginning of the procedure. None of the patients underwent monitoring of spinal cord evoked potentials, nor drainage of their cerebrospinal fluid (CSF) pre-operatively to prevent SCI. Primary technical success was defined as successful deployment of the stent-graft without conversion to open surgery or mortality during the procedure and without any resulting type I or III endoleak. 7 For dissection, persistent false lumen flow was not considered an endoleak unless it arose from the primary entry tear. If any unplanned endovascular or surgical procedures were required to achieve the desired result, the term primary assisted technical success was used.
Length of aortic coverage
The length of aortic coverage was measured either during the procedure using a calibrated catheter or during control CT-scan using centre-line measurements, when the aorta was tortuous.
Surveillance
Paraplegia or paraparesis upon awakening after the procedure was defined as immediate neurological impairment. Neurological impairment preceded by a period during which the patient's neurological examination was normal, was defined as delayed neurological impairment. All the patients with neurological impairment underwent intravenous anticoagulation targeting an ACT of 1.5 to avoid thrombus formation in the spinal cord arterial system, immediate CSF drainage, maintaining their CSF pressure below 10 mmHg for 48 to 72 hours and their MAP above 90 mmHg to increase spinal cord perfusion.
Statistical analysis
The variables considered as potential risk factors for SCI are listed in Table 1 .
Statistical analysis was performed with SPSS for Windows (version 11.5, 2002; SPSS Inc, Chicago, Illinois, USA). Discontinuous variables were compared using the Chi-two-square test or the Fisher probabilities* test, according to appropriateness. Continuous variables (expressed as median and range) were compared using the Mann-Whitney non-parametric U test. Logistic regression was used to assess the adjusted likelihood of SCI. The tests were two-sided and considered as significant when p < 0.05. Bonferroni's correction method was used to correct for multiple tests whenever necessary. Multifactorial analysis was performed using an ascending stepwise method with p ¼ 0.10 as the input and output criterion for the variables. The risk of SCI for the length of aorta covered was assessed using the area under the receiveroperating-characteristic curve (ROC). The threshold values used were those which combined the maximum values of sensitivity and specificity.
Results
Patients
Over a 6-year period, 67 patients underwent endovascular treatment of the thoracic aorta. There were 54 men (80.6%) and 13 women (19.4%). The mean age was 66 years (range 19 to 93 years). Case details are listed in Table 2 .
Deployment of the stent Primary technical success was achieved in 57 patients (85.1%). Conversion to open surgery was necessary in 2 patients:
One patient suffered an aortic rupture during the procedure following balloon inflation for stentgraft deployment and was treated with the addition of a stent-graft and a bypass to the visceral trunk arteries covered by the stent-graft. One patient with chronic dissection had a right renal artery thrombosis secondary to false-lumen thrombosis. He was treated with a right ilio-renal bypass.
At the end of the procedure, 5 patients had a type 1 proximal endoleak, one had a distal type 1 endoleak, and 1 patient had a type III endoleak.
Assisted primary technical success was achieved in 59 patients (88%).
A post-procedure primary endoleak was noted on first follow-up CT-scan in 8 patients (11.0%): 6 of these The length of stent-covered thoracic aorta was significantly greater in patients who underwent stentgraft placement for aneurysm ( p ¼ 0.001). Details of the length of the aorta covered according to the specific disease treated are provided in Table 3 .
To ensure a correct stent-graft attachment and seal, the ''attachment zone'' was adapted in 8 patients (12%) for aortic lesions involving a part of the aortic arch (n ¼ 5) or the visceral segment of the aorta (n ¼ 3).
For the proximal attachment zone, a transposition of the LSA was performed in 3 patients, a combination of an intercarotid and carotid-subclavian bypass in 1 patient, and a combination of an intercarotid bypass and a LSA transposition in 1 patient. The LSA was partially covered without surgical revascularization in 5 patients (7.5%); none of these patients developed left upper limb ischaemia or SCI. For the distal attachment zone, the celiac trunk was covered in 3 patients. Prior embolization was performed in one of these patients. None of these patients developed bowel ischaemia.
Hospital mortality
The univariate analysis showed that the aneurysm etiology ( p ¼ 0.01), COPD ( p ¼ 0.01), number of stents deployed ( p ¼ 0.03), were significant risk factors for hospital mortality. Details of the results of the univariate analysis are given in Table 4 . Among the patients who died, two had paraplegia. The association between postoperative SCI and increased in hospital mortality was of borderline significance ( p ¼ 0.06).
In multivariate analysis only the etiology of the lesion treated (RR ¼ 12.36, CI ¼ 1.92e128.06, p ¼ 0.03) and history of COPD (RR ¼ 11, CI ¼ 1.48e81.45, p ¼ 0.02) were independent risk factors for hospital mortality. 
Spinal cord ischaemia
Five patients (7.5%) had neurological impairment attributed to SCI. All the cases occurred after elective treatment. Two presented with immediate and 3 with delayed impairment within 24 hours following the procedure. Three patients had a complete paraplegia, none recovered and 2 died within 30 days after the procedure. Two patients had mild paraparesis and fully recovered once CSF drainage was initiated and MAP maintained above 90 mmHg. Univariate analysis showed that when a long portion of the aorta was covered ( p < 0.001), or several stents were deployed ( p ¼ 0.02), the risk of postoperative SCI increased significantly. Details of the results are given in Table 5 . Multivariate analysis showed that only the length of aorta covered was an independent risk factor for postoperative SCI (RR ¼ 1.05, CI ¼ 1.01e 1.09, p < 0.001). The ROC curve for the risk of SCI as a function of the length of aorta covered is shown in Fig. 1 , with the area under the curve equal to 0.96 (CI 95%, 0.90e1, p ¼ 0.001). The critical length of aortic coverage for SCI was 205 mm, with an 80% sensitivity (CI 95%, 70.4e89.6) and specificity of 95.2% (CI 95%, 90e100.3). Fig. 2 shows the probability of SCI and its relationship with the length of aorta covered.
Discussion
SCI is a serious complication of the endovascular treatment of lesions of the DTA with a reported frequency that ranges from 0 to 12%. 3, 8 In our study, the rate of SCI was 7.5% with permanent neurological impairment noted in 4.5%, results that are comparable with data in the literature. These results also are comparable with those of surgical series in which the usual rate of SCI ranges between 2.7% and 13.8%, 2, 9 Statistical analysis identified the length of aorta covered as the only independent predictive factor for SCI after endovascular treatment in our series. Two of the 5 patients who had SCI died within 30 days of their procedure, which suggests that these adverse outcomes may be closely related ( p ¼ 0.06). SCI after endovascular treatment occurs more frequently when the arteries that supply the spinal cord are sacrificed (Adamkiewicz's artery, intercostal and lumbar arteries), as well as after a period of hypotension or as a result of emboli from aortic atheromatous lesions. 4 Our results clearly demonstrate that SCI following endovascular treatment mainly is related to the irreversible sacrifice of the intercostal arteries covered by the stent. Above a threshold of 205 mm, the onset of SCI was predictable with a sensitivity and specificity of 80% and 92.5%, respectively. Further, univariate analysis identified the number of stentgrafts deployed ( p ¼ 0.02) as a predictive factor for SCI. The length of aorta covered, as a predictive factor of SCI, was first reported by Greenberg, 3 compatible with the spinal cord vascularization model proposed by Griepp. 10 In Griepp's model, spinal cord vascularization is dependent on many interchangeable collateral arteries that supply the anterior spinal cord artery, rather than a single dominant ''Adamkiewicz artery'', which previously was considered essential for maintaining spinal cord perfusion. Our results are consistent with Griepp's model because the number of intercostal arteries sacrificed increases with the length of aorta covered. However, we have been unable to confirm that patients who have already had AAA repair have a higher risk of SCI, since in the group of 11 patients with history of AAA repair, only one developed SCI.
Although it is an influential model, Griepp's concept does not apply to all clinical situations, especially in terms of the area of aortic coverage. We divided the DTA into thirds and hypothesised that coverage of the distal third would be associated with a greater risk of SCI. Although the association between coverage of the distal third of the aorta and increased SCI was of borderline significance only ( p ¼ 0.07) our study had limited statistical power. Although there are no similar published findings, we suggest that coverage of the distal third of the DTA must be approached with caution, particularly if the patient has other risk factors for development of SCI.
We also analyzed the impact of covering the LSA during endovascular treatment, to determine whether it played a role in generating spinal cord ischaemia: our results showed that it did not appear to be a contributing factor. Since the anterior spinal artery arises from the vertebral artery, an interruption of the flow in the LSA could be associated with this type of complication, especially if the left vertebral artery is dominant. Complications related to occlusion of the LSA are mainly ischaemia of the left upper limb or a stroke in the vertebro-basilar territory. 11 Our study was too small to assess the role of subclavian vascularization in the onset of SCI after placement of a stent-graft.
The only measure we applied systematically to prevent spinal cord ischaemia consisted of maintaining high MAP values throughout procedure until the patients awoke. After occlusion of the intercostal arteries, spinal cord perfusion pressure decreases: perfusion pressure is determined by calculating the gradient between MAP and CSF pressure. Many published articles demonstrate that a decrease in MAP (below 60e70 mmHg) in the peri-operative period is associated with the onset of SCI when thoracic or thoraco-abdominal aneurysms are treated by either conventional surgery 12 or endovascular procedures, 13 and in patients with delayed paraplegia, symptoms regress when hypotension is corrected and combined with CSF drainage. 13 Therefore it is essential to make sure that the patient's haemodynamic status is monitored closely both per-and post-operatively, to maintain MAP values above 90 mmHg. 13, 14 We did not perform either a pre-operative spinal cord angiogram (SCA) because it is an invasive examination which is not exempt from embolic complications and only yields a precise roadmap of spinal cord vascularization in 55 to 85.7% of patients. 15, 16 or peri-operative spinal cord monitoring, which is another means of detecting SCI at an early stage during the placement of thoracic stents. 17 CSF drainage is not used as a routine practice in our group, but it is important as a preventive measure. In a randomized study, 18 investigators demonstrated that CSF drainage has the potential to prevent SCI after surgery for thoracoabdominal aneurysm (TAA) and after surgery for aneurysm of the DTA when it is combined with other prevention methods. 9 Many cases of SCI reversal following CSF drainage have been reported after TAA surgery and after thoracic stenting. In our series, for the patients with delayed SCI (3 cases), CSF drainage effected a clear improvement in a third of the cases, a proportion consistent with figures in the literature. More recently, CSF drainage was proposed as a preventive measure against SCI in high risk patients treated by thoracic stent-grafts. 4, 13, 19, 20 Since there are complications related to CSF drainage, especially the risk of compressive haematoma of the spinal cord, we feel that this technique should be used as a prophylactic measure only in patients in whom the aortic lesion requires stent-graft coverage of a segment longer than 205 mm, and perhaps in those with a prior history of AAA repair and/or poor pelvic vascularization with limited collateral supply.
The main limitation of our study is that it is retrospective, although the data were collected prospectively. The number of patients included is small and the range of patients treated is broad, which limits the statistical power of the study. Also, many of our patients were treated for traumatic rupture (26.8%) or dissection (25.3%), conditions for which we know that the rate of spinal cord ischaemia is low after placement of a stent-graft. However, despite the fact that our study is descriptive, we have added to the evidence that the length of aorta covered is of crucial importance to the development of spinal cord ischaemia after endovascular treatment.
Conclusions
The treatment of patients with lesions of the descending thoracic aorta by stent-grafts can cause SCI. In terms of identifying patients who have an increased risk of developing these neurological complications, the length of aorta covered by the stent-graft was the only independent predictive risk factor for spinal cord ischaemia identified. In our non-controlled prospective series, in patients for whom no systematic preventive measure (CSF drainage, spinal cord evoked potentials) was implemented, apart from strict arterial pressure monitoring, a critical aortic treatment length of 205 mm was a threshold beyond which there exists an elevated risk of SCI. Thus, methods aimed at maintaining spinal cord perfusion pressure (ie, CSF drainage and maintenance of a high MAP) should be proposed for patients whose lesion requires extensive coverage of the descending thoracic aorta. Any strategy aimed at the prevention of SCI must take into account the multiple anatomical, physiological and procedural factors related to this complication.
